Viliami Fehoko

24-Year-Old Defensive EndDE
2023 Fantasy Outlook
There was no outlook written for Viliami Fehoko in 2023. Check out the latest news below for more on his current fantasy value.
$Signed a four-year, $4.53 million contract with the Cowboys in May of 2023.
Returns to active roster
DEDallas Cowboys
January 3, 2024
Fehoko (knee) was activated from injured reserve Wednesday.
ANALYSIS
Fehoko has yet to suit up with the Cowboys this season despite not landing on IR until Nov. 18. The rookie was on the last day of his 21-day practice window, so if Dallas did not activate him, he would have been forced to miss the remainder of the season.
Read More News
NFL Stats
Loading NFL Stats...
2023
2023 NFL Game Log
Calculate Stats Over Time
Just click on any two dates.
Loading Game Log...
Snap Distribution / Depth Chart
Snap Counts
Snap %
Dallas CowboysCowboys 2023 DE Snap Distribution See more data like this | See last season's snap counts
#% of Team Snaps

60856%
44541%
30528%
29527%
25924%
303%
Loading Weekly Snap Counts...
2023 Viliami Fehoko Split Stats
Loading NFL Split Stats...
More Fantasy News
Designated to return from IR
DEDallas Cowboys
Knee
December 13, 2023
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Placed on IR
DEDallas Cowboys
Knee
November 18, 2023
The Cowboys placed Fehoko (knee) on injured reserve Saturday.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Healthy ahead of 2023 campaign
DEDallas Cowboys
September 6, 2023
Fehoko (shoulder) did not appear on the Cowboys' injury report Wednesday, Michael Gehlken of The Dallas Morning News reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Still sidelined
DEDallas Cowboys
Shoulder
August 12, 2023
Fehoko (shoulder) isn't in uniform for Saturday's preseason game against the Jaguars, Todd Archer of ESPN.com reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Dealing with shoulder strain
DEDallas Cowboys
Shoulder
August 8, 2023
Fehoko didn't practice Tuesday due to a shoulder strain, Michael Gehlken of The Dallas Morning News reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.